These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 14725582
41. Systematic review and meta-analysis: enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia--a post hoc analysis from the Cochrane Collaboration. Leontiadis GI, Sharma VK, Howden CW. Aliment Pharmacol Ther; 2005 May 01; 21(9):1055-61. PubMed ID: 15854166 [Abstract] [Full Text] [Related]
42. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials. Scally B, Emberson JR, Spata E, Reith C, Davies K, Halls H, Holland L, Wilson K, Bhala N, Hawkey C, Hochberg M, Hunt R, Laine L, Lanas A, Patrono C, Baigent C. Lancet Gastroenterol Hepatol; 2018 Apr 01; 3(4):231-241. PubMed ID: 29475806 [Abstract] [Full Text] [Related]
43. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI. Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H. Hepatogastroenterology; 2004 Apr 01; 51(56):338-42. PubMed ID: 15086153 [Abstract] [Full Text] [Related]
44. Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding. Gisbert JP, Calvet X, Cosme A, Almela P, Feu F, Bory F, Santolaria S, Aznárez R, Castro M, Fernández N, García-Grávalos R, Benages A, Cañete N, Montoro M, Borda F, Pérez-Aisa A, Piqué JM, H. pylori Study Group of the Asociación Española de Gastroenterología (Spanish Gastroenterology Association). Am J Gastroenterol; 2012 Aug 01; 107(8):1197-204. PubMed ID: 22613904 [Abstract] [Full Text] [Related]
45. [Mucosa protective therapy with long-term nonsteroidal antirheumatic drugs]. Cozzarini W, Rath J, Bauer A, Györög I, Györög M, Prenner M, Trianto T, Maderbacher H, Höller E, Grusch B, Sebesta C. Wien Med Wochenschr; 2003 Aug 01; 153(13-14):295-303. PubMed ID: 12924104 [Abstract] [Full Text] [Related]
46. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study. Nagata N, Niikura R, Sekine K, Sakurai T, Shimbo T, Kishida Y, Tanaka S, Aoki T, Okubo H, Watanabe K, Yokoi C, Akiyama J, Yanase M, Mizokami M, Uemura N. J Gastroenterol Hepatol; 2015 Feb 01; 30(2):292-8. PubMed ID: 25339607 [Abstract] [Full Text] [Related]
60. Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage. Lai KC, Hui WM, Wong BC, Hu WH, Lam SK. Aliment Pharmacol Ther; 2000 Aug 01; 14(8):1071-6. PubMed ID: 10930902 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]